GreyMatter Capital is a venture capital firm dedicated to empowering founders who are innovating in the mental health and emotional wellness space, believing that innovation in mental wellbeing can transform not just healthcare, but the way we live, work, and connect. They focus on early-stage companies with tech solutions to transform mental health by reimagining care delivery through targeted support and deep sector expertise.
About GreyMatter Capital
GreyMatter Capital is an investment firm with a greymattercapital.com website and LinkedIn presence, with a generalist or specialist thesis that the public footprint does not clearly disclose for healthcare or AI. For healthcare AI founders, this is a peripheral fund best understood as potential syndicate capital rather than a thesis-aligned lead investor. Plausible check sizes for partnerships of this profile run 100K to 750K at seed and pre-seed, supporting rounds led by larger or more specialized firms. Founders building horizontal AI software with healthcare applications or healthcare-flavored B2B SaaS could open a conversation if they have clear team and traction signals. Founders building regulated medical devices, therapeutics, or clinical AI requiring deep healthcare networks should look at healthcare-native firms. Entry path is LinkedIn direct outreach to partners with a tight, sharply positioned pitch. Do not expect deep healthcare-specific diligence or sector value-add. Realistic founder triage: small partnerships without published healthcare focus offer limited differentiated value for healthcare AI founders. Allocate fundraising hours to firms with demonstrable healthcare conviction and portfolio. Approach GreyMatter only as a syndicate participant once a thesis-aligned lead is committed, and treat any check as additive capital. Avoid handing this fund governance influence given the absence of demonstrated healthcare expertise. The honest read is that founders should not invest meaningful pitch energy here when better-aligned options exist; spending an hour with a healthcare-native investor will move the round forward more than spending an hour with a small generalist whose value-add is uncertain.
Founder reviews
Healthcare AI tools backed by GreyMatter Capital
Tools made by companies in GreyMatter Capital's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in GreyMatter Capital's portfolio not currently in our directory.
- Applied Cognition
- Blackbird
- Brevy · 2026
- Coral Care · 2026
- Elera · 2026
- Era
- FamilyWell · 2025
- Finni
- firsthand
- Kibu
Team
Pitch / review this investor
Have you raised from GreyMatter Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).